| Dr Ferdinand C Martinez, MD | |
|
3000 Mon Health Medical Park Dr Ste 3201, Morgantown, WV 26505-1170 | |
| (304) 285-1460 | |
| (304) 285-2739 |
| Full Name | Dr Ferdinand C Martinez |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 25 Years |
| Location | 3000 Mon Health Medical Park Dr Ste 3201, Morgantown, West Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194911107 | NPI | - | NPPES |
| 26059 | Other | WV | WV BOARD OF MEDICINE |
| MD431880 | Other | PA | MD431880 |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | MD0431880 (Pennsylvania) | Secondary |
| 208600000X | Surgery | 26059 (West Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Stonewall Jackson Memorial Hospital | Weston, WV | Hospital |
| Preston Memorial Hospital | Kingwood, WV | Hospital |
| Mon Health Medical Center | Morgantown, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Stonewall Jackson Memorial Hospital Company | 4284530551 | 42 |
| Monongalia County General Hospital Company | 9638073380 | 182 |
News Archive
USA Today reports prices may be higher than expected for some middle-class consumers who are not eligible for the health law's subsidies. Meanwhile, Politico highlights how one group - older Capitol Hill staffers - is reacting to this marketplace experience.
W. L. Gore & Associates reported that the first patient, in an Investigational Device Exemption (IDE) clinical study evaluating the self sealing GORE® ACUSEAL Vascular Graft in patients on hemodialysis, has been surgically implanted with the device. The successful surgical procedure was performed on July 29, 2010 at Greenville Hospital System in Greenville, South Carolina. Less than 24 hours after the device was implanted it was successfully cannulated or punctured for initial hemodialysis access.
The intestinal ecosystem is even more dynamic than previously thought, according to two studies by UT Southwestern Medical Center researchers published in the latest issue of Science.
In adults with prediabetes, a new drug that alters microbial populations and their environment in the gastrointestinal (GI) tract improves glucose tolerance-the body's response to consuming carbohydrates- after four weeks of treatment and without a change in diet.
GTx, Inc. announced today that it has entered into a securities purchase agreement with J.R. Hyde, III, the chairman of GTx's Board of Directors, and The Pyramid Peak Foundation, to issue and sell in a private placement to these purchasers an aggregate of 11,976,048 immediately separable units, comprised of an aggregate of 11,976,048 shares of GTx common stock and warrants to purchase up to 10,179,642 additional shares of common stock.
› Verified 7 days ago
| Entity Name | Monongalia County General Hospital Company |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447673223 PECOS PAC ID: 9638073380 Enrollment ID: O20031124000459 |
News Archive
USA Today reports prices may be higher than expected for some middle-class consumers who are not eligible for the health law's subsidies. Meanwhile, Politico highlights how one group - older Capitol Hill staffers - is reacting to this marketplace experience.
W. L. Gore & Associates reported that the first patient, in an Investigational Device Exemption (IDE) clinical study evaluating the self sealing GORE® ACUSEAL Vascular Graft in patients on hemodialysis, has been surgically implanted with the device. The successful surgical procedure was performed on July 29, 2010 at Greenville Hospital System in Greenville, South Carolina. Less than 24 hours after the device was implanted it was successfully cannulated or punctured for initial hemodialysis access.
The intestinal ecosystem is even more dynamic than previously thought, according to two studies by UT Southwestern Medical Center researchers published in the latest issue of Science.
In adults with prediabetes, a new drug that alters microbial populations and their environment in the gastrointestinal (GI) tract improves glucose tolerance-the body's response to consuming carbohydrates- after four weeks of treatment and without a change in diet.
GTx, Inc. announced today that it has entered into a securities purchase agreement with J.R. Hyde, III, the chairman of GTx's Board of Directors, and The Pyramid Peak Foundation, to issue and sell in a private placement to these purchasers an aggregate of 11,976,048 immediately separable units, comprised of an aggregate of 11,976,048 shares of GTx common stock and warrants to purchase up to 10,179,642 additional shares of common stock.
› Verified 7 days ago
| Entity Name | Stonewall Jackson Memorial Hospital Company |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477559433 PECOS PAC ID: 4284530551 Enrollment ID: O20040130000739 |
News Archive
USA Today reports prices may be higher than expected for some middle-class consumers who are not eligible for the health law's subsidies. Meanwhile, Politico highlights how one group - older Capitol Hill staffers - is reacting to this marketplace experience.
W. L. Gore & Associates reported that the first patient, in an Investigational Device Exemption (IDE) clinical study evaluating the self sealing GORE® ACUSEAL Vascular Graft in patients on hemodialysis, has been surgically implanted with the device. The successful surgical procedure was performed on July 29, 2010 at Greenville Hospital System in Greenville, South Carolina. Less than 24 hours after the device was implanted it was successfully cannulated or punctured for initial hemodialysis access.
The intestinal ecosystem is even more dynamic than previously thought, according to two studies by UT Southwestern Medical Center researchers published in the latest issue of Science.
In adults with prediabetes, a new drug that alters microbial populations and their environment in the gastrointestinal (GI) tract improves glucose tolerance-the body's response to consuming carbohydrates- after four weeks of treatment and without a change in diet.
GTx, Inc. announced today that it has entered into a securities purchase agreement with J.R. Hyde, III, the chairman of GTx's Board of Directors, and The Pyramid Peak Foundation, to issue and sell in a private placement to these purchasers an aggregate of 11,976,048 immediately separable units, comprised of an aggregate of 11,976,048 shares of GTx common stock and warrants to purchase up to 10,179,642 additional shares of common stock.
› Verified 7 days ago
| Entity Name | Preston Memorial Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841230661 PECOS PAC ID: 5294645107 Enrollment ID: O20040609000164 |
News Archive
USA Today reports prices may be higher than expected for some middle-class consumers who are not eligible for the health law's subsidies. Meanwhile, Politico highlights how one group - older Capitol Hill staffers - is reacting to this marketplace experience.
W. L. Gore & Associates reported that the first patient, in an Investigational Device Exemption (IDE) clinical study evaluating the self sealing GORE® ACUSEAL Vascular Graft in patients on hemodialysis, has been surgically implanted with the device. The successful surgical procedure was performed on July 29, 2010 at Greenville Hospital System in Greenville, South Carolina. Less than 24 hours after the device was implanted it was successfully cannulated or punctured for initial hemodialysis access.
The intestinal ecosystem is even more dynamic than previously thought, according to two studies by UT Southwestern Medical Center researchers published in the latest issue of Science.
In adults with prediabetes, a new drug that alters microbial populations and their environment in the gastrointestinal (GI) tract improves glucose tolerance-the body's response to consuming carbohydrates- after four weeks of treatment and without a change in diet.
GTx, Inc. announced today that it has entered into a securities purchase agreement with J.R. Hyde, III, the chairman of GTx's Board of Directors, and The Pyramid Peak Foundation, to issue and sell in a private placement to these purchasers an aggregate of 11,976,048 immediately separable units, comprised of an aggregate of 11,976,048 shares of GTx common stock and warrants to purchase up to 10,179,642 additional shares of common stock.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ferdinand C Martinez, MD 3000 Mon Health Medical Park Dr Ste 3201, Morgantown, WV 26505-1170 Ph: (304) 285-1460 | Dr Ferdinand C Martinez, MD 3000 Mon Health Medical Park Dr Ste 3201, Morgantown, WV 26505-1170 Ph: (304) 285-1460 |
News Archive
USA Today reports prices may be higher than expected for some middle-class consumers who are not eligible for the health law's subsidies. Meanwhile, Politico highlights how one group - older Capitol Hill staffers - is reacting to this marketplace experience.
W. L. Gore & Associates reported that the first patient, in an Investigational Device Exemption (IDE) clinical study evaluating the self sealing GORE® ACUSEAL Vascular Graft in patients on hemodialysis, has been surgically implanted with the device. The successful surgical procedure was performed on July 29, 2010 at Greenville Hospital System in Greenville, South Carolina. Less than 24 hours after the device was implanted it was successfully cannulated or punctured for initial hemodialysis access.
The intestinal ecosystem is even more dynamic than previously thought, according to two studies by UT Southwestern Medical Center researchers published in the latest issue of Science.
In adults with prediabetes, a new drug that alters microbial populations and their environment in the gastrointestinal (GI) tract improves glucose tolerance-the body's response to consuming carbohydrates- after four weeks of treatment and without a change in diet.
GTx, Inc. announced today that it has entered into a securities purchase agreement with J.R. Hyde, III, the chairman of GTx's Board of Directors, and The Pyramid Peak Foundation, to issue and sell in a private placement to these purchasers an aggregate of 11,976,048 immediately separable units, comprised of an aggregate of 11,976,048 shares of GTx common stock and warrants to purchase up to 10,179,642 additional shares of common stock.
› Verified 7 days ago
Dr. Matthew Craig Cindric, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1200 J D Anderson Dr, Morgantown, WV 26505 Phone: 304-598-1996 Fax: 304-285-2107 | |
Dr. Frank Cantrell Griswold, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 200 Wedgewood Dr, Suite 202, Morgantown, WV 26505 Phone: 304-599-1905 Fax: 304-599-5335 | |
David Randall Hofius, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 3000 Mon Health Medical Park Dr Ste 3300, Morgantown, WV 26505 Phone: 304-599-1448 Fax: 304-599-5335 | |
Jerome Gordon Johnson, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 1000 Mon Health Medical Park Dr, Suite 1100, Morgantown, WV 26505 Phone: 304-599-1448 Fax: 304-599-5335 | |
Dr. Majed Youssef Maalouf, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Morgantown, WV 26506 Phone: 855-988-2273 | |
Dr. Alison Wilson, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1 Stadium Drive, Morgantown, WV 26506 Phone: 304-598-4800 | |
Dr. Ehab A Akkary, MD Surgery Medicare: Medicare Enrolled Practice Location: 1100 Fort Pierpont Dr Ste 101, Morgantown, WV 26508 Phone: 304-241-1100 Fax: 304-983-8800 |